Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex

Código QR

Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex

Abstract Angiotensin converting enzyme 2 (ACE2) is a key regulator of the renin-angiotensin system, but also the functional receptor of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on structural similarity with other γ-secretase (γS) targets, we hypothesized that ACE2 may...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alberto Bartolomé, Jiani Liang, Pengfei Wang, David D. Ho, Utpal B. Pajvani
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/1aa72151492a40cfb224c6aefc913fef
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Visualizing active enzyme complexes using a photoreactive inhibitor for proximity ligation--application on γ-secretase.
por: Sophia Schedin-Weiss, et al.
Publicado: (2013)

Mechanism of intramembrane cleavage of alcadeins by γ-secretase.
por: Yi Piao, et al.
Publicado: (2013)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang C, et al.
Publicado: (2021)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Marco Rossato, et al.
Publicado: (2020)

Presenilin/γ-secretase regulates neurexin processing at synapses.
por: Carlos A Saura, et al.
Publicado: (2011)

Γ-secretase components as predictors of breast cancer outcome.
por: Hanna M Peltonen, et al.
Publicado: (2013)

Role of cholesterol in substrate recognition by $$\gamma$$ γ -secretase
por: Łukasz Nierzwicki, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Bin Tu, et al.
Publicado: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
por: Miklós Fagyas, et al.
Publicado: (2014)

Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
por: Xiao-Yu Xin, et al.
Publicado: (2021)

Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
por: Fengxia Xiao, et al.
Publicado: (2012)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Maki Komiyama, et al.
Publicado: (2020)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
por: Jin-Ying Fang, et al.
Publicado: (2020)

A novel angiotensin I-converting enzyme inhibitory peptide derived from the trypsin hydrolysates of salmon bone proteins.
por: Thanakrit Kaewsahnguan, et al.
Publicado: (2021)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Brittany L. Fowler, et al.
Publicado: (2021)

The Chemical Compounds of Flacourtia rukam Leaves and Their Inhibition of Angiotensin-converting Enzyme (ACE) Activity
por: Muharni Muharni, et al.
Publicado: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
por: Miklós Fagyas, et al.
Publicado: (2014)

A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence
por: Gonjin Song, et al.
Publicado: (2021)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
por: Meng-Yuan Liu, et al.
Publicado: (2020)

Antioxidant properties and inhibition of angiotensin-converting enzyme by highly active peptides from wheat gluten
por: Wen-Ying Liu, et al.
Publicado: (2021)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
por: Osama A. Amin, et al.
Publicado: (2021)

Relationship of quadriceps muscle power and optimal shortening velocity with angiotensin-converting enzyme activity in older women
por: Kostka J, et al.
Publicado: (2017)

COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
por: Lingli Xie, et al.
Publicado: (2021)

Spike protein of the SARS-CoV-2 virus and its relationship with the angiotensin-converting enzyme-2
por: María Teresa Díaz-Armas, et al.
Publicado: (2021)

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.
por: Jia Yao, et al.
Publicado: (2021)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
por: O. K. Vikulova, et al.
Publicado: (2020)

Single nucleotide polymorphisms of the angiotensin-converting enzyme (ACE) gene are associated with essential hypertension and increased ACE enzyme levels in Mexican individuals.
por: Nancy Martínez-Rodríguez, et al.
Publicado: (2013)

Targeting &gamma;-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)

Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats.
por: Yixiong Chen, et al.
Publicado: (2012)

Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Youssef M. Mousa, et al.
Publicado: (2020)

Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
por: Seung-Hwa Lee, et al.
Publicado: (2021)

In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2
por: Farzaneh Jafary, et al.
Publicado: (2021)

Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.
por: Ya-Feng Li, et al.
Publicado: (2012)

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
por: Fatai S. Oladunni, et al.
Publicado: (2020)

Bioactivity-Guided Fractionation of Pine Needle Reveals Catechin as an Anti-hypertension Agent via Inhibiting Angiotensin-Converting Enzyme
por: Jian He
Publicado: (2017)

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
por: Thomas J. Esparza, et al.
Publicado: (2020)

Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis
por: Mohitosh Biswas, et al.
Publicado: (2021)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

ER-associated degradation regulates Alzheimer’s amyloid pathology and memory function by modulating γ-secretase activity
por: Bing Zhu, et al.
Publicado: (2017)

Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.
por: José T Ortiz-Pérez, et al.
Publicado: (2013)